 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Elixir develops and commercializes therapeutics to treat age-related diseases, with a focus on metabolic diseases such as diabetes and obesity. This mission is made possible by the recent discovery of genes that both control aging and have a direct effect on our targeted metabolic diseases. Elixir is accomplishing this goal by aggressively growing both internal discovery programs and in-licensing strategic commercial opportunities. |
|
 |
 |
 |
 |
|
Technology Department | June 13, 2008 | Contact |